hsa-miR-21-5p can serve as a standard biomarker in clear cell renal cell carcinoma by promoting tumor progression and influencing immune evasion
{{output}}
The increased expression of hsa-miR-21-5p in clear cell renal cell carcinoma (ccRCC) patients is closely linked to poor overall survival. Our predictive model, validated through tumor grading and staging, corresponds with enrichment analysis results and is fur... ...
